LGC Standards has announced the addition of the PrimacyT range of in-vitro products and services to its portfolio of life-science research and drug-discovery products.
PrimacyT currently offers hepatocyte cells to the drug-discovery research community throughout Europe and the partnership with LGC Standards will facilitate a wider distribution of these cells and allow greater access to these important in-vitro models.
The drug-development community recognises the need for improved in-vitro modelling systems and the collaboration between LGC - which holds the designated role as the UK's National Measurement Institute for chemical and bioanalytical measurement - and companies such as PrimacyT provide a platform from which to develop new and more effective in-vitro systems and to facilitate their distribution.
